PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2019 • Market size and forecast 2019-2024 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY PRODUCT • Market segmentation by product • Comparison by product • Drugs - Market size and forecast 2019-2024 • Devices - Market size and forecast 2019-2024 • Market opportunity by product PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2019-2024 • Europe - Market size and forecast 2019-2024 • Asia - Market size and forecast 2019-2024 • ROW - Market size and forecast 2019-2024 • Key leading countries • Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS • Growth in adoption of companion animals • Increasing preference for non-conventional and non-pharmaceutical • treatments • Rising demand for pet insurance with growing animal health expenditure PART 12: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive scenario PART 13: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Bayer AG • Boehringer Ingelheim International GmbH • Cadila Healthcare Ltd. • Chanelle Pharma Group • Daiichi Sankyo Co. Ltd. • Dechra Pharmaceuticals Plc • Elanco Animal Health Inc. • Merck & Co. Inc. • Norbrook Holdings Ltd. • Zoetis Inc. PART 14: APPENDIX • Research methodology • List of abbreviations • Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Product overview Exhibit 02: Global pharmaceuticals market Exhibit 03: Segments of global pharmaceuticals market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2019 Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions) Exhibit 09: Global market: Year-over-year growth 2020-2024 (%) Exhibit 10: Five forces analysis 2019 Exhibit 11: Five forces analysis 2024 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2019 Exhibit 18: Product - Market share 2019-2024 (%) Exhibit 19: Comparison by product Exhibit 20: Drugs - Market size and forecast 2019-2024 ($ millions) Exhibit 21: Drugs - Year-over-year growth 2020-2024 (%) Exhibit 22: Devices - Market size and forecast 2019-2024 ($ millions) Exhibit 23: Devices - Year-over-year growth 2020-2024 (%) Exhibit 24: Market opportunity by product Exhibit 25: Customer landscape Exhibit 26: Market share by geography 2019-2024 (%) Exhibit 27: Geographic comparison Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions) Exhibit 29: North America - Year-over-year growth 2020-2024 (%) Exhibit 30: Top 3 countries in North America Exhibit 31: Europe - Market size and forecast 2019-2024 ($ millions) Exhibit 32: Europe - Year-over-year growth 2020-2024 (%) Exhibit 33: Top 3 countries in Europe Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions) Exhibit 35: Asia - Year-over-year growth 2020-2024 (%) Exhibit 36: Top 3 countries in Asia Exhibit 37: ROW - Market size and forecast 2019-2024 ($ millions) Exhibit 38: ROW - Year-over-year growth 2020-2024 (%) Exhibit 39: Top 3 countries in ROW Exhibit 40: Key leading countries Exhibit 41: Market opportunity Exhibit 42: Impact of drivers and challenges Exhibit 43: Vendor landscape Exhibit 44: Landscape disruption Exhibit 45: Vendors covered Exhibit 46: Vendor classification Exhibit 47: Market positioning of vendors Exhibit 48: Bayer AG - Vendor overview Exhibit 49: Bayer AG - Business segments Exhibit 50: Bayer AG - Organizational developments Exhibit 51: Bayer AG - Geographic focus Exhibit 52: Bayer AG - Segment focus Exhibit 53: Bayer AG - Key offerings Exhibit 54: Bayer AG - Key customers Exhibit 55: Boehringer Ingelheim International GmbH - Vendor overview Exhibit 56: Boehringer Ingelheim International GmbH - Product segments Exhibit 57: Boehringer Ingelheim International GmbH - Organizational developments Exhibit 58: Boehringer Ingelheim International GmbH - Geographic focus Exhibit 59: Boehringer Ingelheim International GmbH - Segment focus Exhibit 60: Boehringer Ingelheim International GmbH - Key offerings Exhibit 61: Boehringer Ingelheim International GmbH - Key customers Exhibit 62: Cadila Healthcare Ltd. - Vendor overview Exhibit 63: Cadila Healthcare Ltd. - Business segments Exhibit 64: Cadila Healthcare Ltd. - Organizational developments Exhibit 65: Cadila Healthcare Ltd. - Geographic focus Exhibit 66: Cadila Healthcare Ltd. - Key offerings Exhibit 67: Cadila Healthcare Ltd. - Key customers Exhibit 68: Chanelle Pharma Group - Vendor overview Exhibit 69: Chanelle Pharma Group - Business segments Exhibit 70: Chanelle Pharma Group - Organizational developments Exhibit 71: Chanelle Pharma Group - Key offerings Exhibit 72: Chanelle Pharma Group - Key customers Exhibit 73: Daiichi Sankyo Co. Ltd. - Vendor overview Exhibit 74: Daiichi Sankyo Co. Ltd. - Business segments Exhibit 75: Daiichi Sankyo Co. Ltd. - Organizational developments Exhibit 76: Daiichi Sankyo Co. Ltd. - Geographic focus Exhibit 77: Daiichi Sankyo Co. Ltd. - Key offerings Exhibit 78: Daiichi Sankyo Co. Ltd. - Key customers Exhibit 79: Dechra Pharmaceuticals Plc - Vendor overview Exhibit 80: Dechra Pharmaceuticals Plc - Product segments Exhibit 81: Dechra Pharmaceuticals Plc - Organizational developments Exhibit 82: Dechra Pharmaceuticals Plc - Geographic focus Exhibit 83: Dechra Pharmaceuticals Plc - Segment focus Exhibit 84: Dechra Pharmaceuticals Plc - Key offerings Exhibit 85: Dechra Pharmaceuticals Plc - Key customers Exhibit 86: Elanco Animal Health Inc. - Vendor overview Exhibit 87: Elanco Animal Health Inc. - Product segments Exhibit 88: Elanco Animal Health Inc. - Organizational developments Exhibit 89: Elanco Animal Health Inc. - Geographic focus Exhibit 90: Elanco Animal Health Inc. - Segment focus Exhibit 91: Elanco Animal Health Inc. - Key offerings Exhibit 92: Elanco Animal Health Inc. - Key customers Exhibit 93: Merck & Co. Inc. - Vendor overview Exhibit 94: Merck & Co. Inc. - Business segments Exhibit 95: Merck & Co. Inc. - Organizational developments Exhibit 96: Merck & Co. Inc. - Geographic focus Exhibit 97: Merck & Co. Inc. - Segment focus Exhibit 98: Merck & Co. Inc. - Key offerings Exhibit 99: Merck & Co. Inc. - Key customers Exhibit 100: Norbrook Holdings Ltd. - Vendor overview Exhibit 101: Norbrook Holdings Ltd. - Product segments Exhibit 102: Norbrook Holdings Ltd. - Organizational developments Exhibit 103: Norbrook Holdings Ltd. - Geographic focus Exhibit 104: Norbrook Holdings Ltd. - Segment focus Exhibit 105: Norbrook Holdings Ltd. - Key offerings Exhibit 106: Norbrook Holdings Ltd. - Key customers Exhibit 107: Zoetis Inc. - Vendor overview Exhibit 108: Zoetis Inc. - Product segments Exhibit 109: Zoetis Inc. - Organizational developments Exhibit 110: Zoetis Inc. - Geographic focus Exhibit 111: Zoetis Inc. - Segment focus Exhibit 112: Zoetis Inc. - Key offerings Exhibit 113: Zoetis Inc. - Key customers Exhibit 114: Validation techniques employed for market sizing Exhibit 115: Definition of market positioning of vendors

• Bayer AG • Boehringer Ingelheim International GmbH • Cadila Healthcare Ltd. • Chanelle Pharma Group • Daiichi Sankyo Co. Ltd. • Dechra Pharmaceuticals Plc • Elanco Animal Health Inc. • Merck & Co. Inc. • Norbrook Holdings Ltd. • Zoetis Inc.